|
|
||||||||
J Thorac Cardiovasc Surg 2003;125:1083-1090
© 2003 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
From the Service de Chirurgie Cardiaque,a Hôpital Necker-Enfants Malades, Service d'Anatomo-Pathologie,b and Hôpital Européen Georges Pompidou and Laboratoire d'Immunologie Pulmonaire,c UFR Biomédicale des Saints Pères, Faculté Paris V, Paris, France.
This work was supported by APPCC (Paris, France) and SESERAC (Paris, France).
Received for publication April 17, 2002. Revisions requested May 30, 2002; revisions received July 25, 2002. Accepted for publication Aug 15, 2002. Address for reprints: Marilyne Lévy, MD, Hôpital Necker-Enfants Malades, 149 rue de Sevres, 75015 Paris, France (E-mail: marilyne.levy{at}nck.ap-hop-paris.fr).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The vascular endothelium is known to play a crucial role in the local regulation of pulmonary vascular tone and in smooth muscle cell function.
6-8 The vascular endothelium produces and releases a variety of substances. Among them, nitric oxide is a potent endothelium-derived vasorelaxant that prevents the proliferation of smooth muscle cells.
7 Endothelin 1 (ET-1) is also a potent endothelium-derived peptide with vasoconstrictive and mitogenic properties.
9,10 In adult patients with pulmonary hypertension, the expression of endothelial nitric oxide synthase (eNOS) has been shown to decrease, and that of ET-1 has been shown to increase.
11,12
On the basis of these considerations, we postulated that the pulmonary circulation was involved in failure of the Fontan procedure, despite the satisfactory hemodynamic criteria of the patients concerned. To support this hypothesis, we attempted to determine whether the structure of the pulmonary arteries or endothelial expression of vasoactive substances were altered in these patients.
| Methods |
|---|
|
|
|---|
Of the 66 patients who underwent the Fontan procedure at the Laennec and Necker-Enfants Malades hospitals between 1993 and 1999, 17 patients aged 2 to 23 years (median, 6 years) had a lung biopsy analysis. The aim of the study was explained to only 30 patients and their families, depending on the impact of the surgeon on the study, and the biopsy specimen was taken with their agreement for 14 patients. We also analyzed 3 postmortem specimens from patients who died as a result of the Fontan procedure before the study period. The other patients underwent the Fontan procedure without lung biopsy. No difference could be found between the patients who underwent the Fontan procedure with or without lung biopsy according to sex, age, and hemodynamic parameters.
Of the 17 patients, the last 5 had a fenestrated Fontan operation. The fenestration was chosen arbitrarily to facilitate the postoperative course. We performed a histomorphometric analysis of these specimens and used immunochemistry to assess eNOS and ET-1 expression.
The clinical and hemodynamic data for our 17 patients, including previous surgical procedures, are shown in Table 1. All patients underwent cardiac catheterization before the Fontan procedure with oxygen and nitric oxide challenge. The time period between catheterization and lung biopsy was less than 1 month. Because most children were referred from institutions in which the techniques for measuring oxygen consumption in small children were not always available, we reported their pulmonary pressures and pulmonary/systemic flow ratios (Table 1
). Patients were considered as good candidates for the Fontan procedure on the basis of good ventricular function, absence of atrioventricular valve regurgitation, and indirect factors assuming low pulmonary resistance. Because increased eNOS levels could be related to liver dysfunction, we evaluated liver function, which was normal in all patients. Patients were retrospectively divided into 2 groups on the basis of successful or unsuccessful surgical results. Group 1 comprised 8 patients aged 6 to 16 years (median, 10 years) with satisfactory results, and group 2 comprised 9 patients aged 2 to 23 years (median, 3.5 years) with poor results defined as takedown, prolonged pleural effusion requiring chest tube drainage for more than 14 days and hospitalization for more than 21 days, or death. With the exception of age (10.4 ± 3.7 vs 5.7 ± 6.6 years, P = .04), other factors, such as the hemoglobin level, saturation, and pulmonary pressure (17.3 ± 1.6 vs 17.4 ± 1.3 g/dL [P = .76], 77.1% ± 6.8% vs 75.1% ± 6.2% [P = .15], and 13.8 ± 2.4 vs 14.4 ± 3 mm Hg [P = .8], respectively), were comparable in both groups. We did not find any difference in the previous surgical management, the degree of pulmonary vascular bed protection, or the age at the first operation that could explain the difference in outcome of the Fontan procedure. In addition, no difference was observed in the patients who had a fenestrated Fontan procedure (3 in group 1 and 2 in group 2). The myocardial protection and aortic crossclamp times were comparable in all cases, and the postoperative management included pulmonary vasodilators, such as inhaled nitric oxide and spontaneous breathing, if possible. All the patients had postoperative measurement of the pressure in the Fontan circuit and measurement of the transpulmonary gradient. The transpulmonary gradient was significantly higher in group 2 patients than in group 1 patients (P = .01). The takedown was decided on the basis of hemodynamic deterioration with increased transpulmonary gradient or increased left pulmonary pressure caused by ventricular failure confirmed with the echocardiogram. Surgical biopsy specimens were also analyzed from 6 control subjects (aged 3 months to 9 years; median, 0.5 years) who died of no pulmonary cause (3 of sudden infant death syndrome and 3 of cerebral tumors). Although patients who died of sudden infant death syndrome are younger than those in our patient population, we considered them as relevant control subjects because histomorphometric studies have shown that by the age of 4 to 6 months, arterial structure is similar to that observed in older children.
13
|
Histomorphometric study
Serial paraffin-embedded 4-µm-thick sections were stained with hematoxylin and eosin, Perls stain for iron, and modified orcein for elastic fibers. In each biopsy specimen the pulmonary vascular structure was analyzed by using quantitative morphometric techniques, as previously described.
13-15 Pulmonary arterial muscularity was assessed by determining the mean percentage arterial medial thickness of at least 40 arteries in different size ranges and was compared with the normal values for age. The proportion of muscular, partially muscular, and nonmuscular arteries accompanying terminal and respiratory bronchioles and alveolar ducts was also assessed to evaluate potential muscle extension to more peripheral arteries than is normal for age. In each biopsy specimen the size of the intra-acinar arteries was determined by measuring the external diameter of all intra-acinar arteries cut in a perpendicular fashion. We calculated the mean external diameter at each airway level. The measurements were performed by 2 blinded observers. Because the Heath-Edwards grades are inappropriate for assessing pulmonary hypertension in congenital heart disease and because the Rabinovitch classification concerns more severe lesions than that observed in our population, we scored the morphometric grades of lung biopsy specimens as follows: normal, normal arterial medial thickness of proximal and distal pulmonary arteries with no intimal damage (Figure 1, A); grade 1, medial hypertrophy of proximal arteries less than 2x normal but normal medial thickness of distal arteries accompanying alveolar ducts and alveolar walls; grade 2, medial hypertrophy of proximal and distal pulmonary arteries less than twice the normal wall thickness; grade 3, medial hypertrophy of proximal and distal arteries more than twice the normal wall thickness (Figure 1
, B); and grade 4, intimal thickening.
|
Immunohistochemical analysis
Serial paraffin sections of lung tissue were immunostained with antiserum to human eNOS (Transduction Laboratory) and to ET-1 (affinity bioreagent, Golden). All the slides were stained and developed at the same time to avoid variability. Tissue sections were deparaffinized in toluene, rehydrated through graded concentrations of ethanol to water, and heated for 40 minutes in buffered citrate at pH 6. Slides were incubated in hydrogen peroxide to block endogenous peroxidase activity, washed in Tris-buffered saline solution, and incubated for 1 hour with anti-NOS (diluted 1:100) or anti-ET-1 (diluted 1:200) primary antibodies or with normal serum used as a negative control. Sections were then incubated for 15 minutes with a biotinylated secondary antibody and stained with streptavidine labeled with peroxidase, according to the manufacturer's instructions (Dako Corp). Slides were counterstained with Harris hematoxylin. Three investigators blinded to all clinical information examined all the slides to assess interobserver variations. They used a semiquantitative system to grade the staining intensity (0, no staining; 4, maximal staining). No significant difference between observers was noted. The staining was evaluated for both the proximal (>100 µm) and distal (50-100_µm) intra-acinar arteries and the capillaries. Because the immunostaining was similar in different-sized arteries, we pooled these results. We retrospectively assigned the data to the patients and divided them into 3 groups (group 1, group 2, and the control group). We expressed the results as a score (mean ± SD of determinations performed on 20 arteries by all investigators).
Statistical analysis
Results are expressed as means ± SD. The significance of differences between groups was assessed by the Student t test or Fisher exact test, as appropriate. The Pearson coefficient was used to calculate correlations.
| Results |
|---|
|
|
|---|
Histomorphometric study
Histomorphometric study data are shown in Figures 1
and 2. Seven of the 8 patients who had good outcomes (group 1) exhibited normal distal intra-acinar pulmonary arteries (external diameter, <50 µm), and 1 patient exhibited muscle extension into the distal arteries. This patient had postoperative pleural effusion for 12 days. In this group the percentage wall thickness of the distal arteries was low (9.6% ± 2.5%) and was comparable with normal values for age.
13 All patients exhibited a small increase in proximal intra-acinar artery thickness, but the difference versus values in the normal control subjects was not significant.
|
It is noteworthy that none of the patients with normal criteria for the distal intra-acinar pulmonary artery died of the Fontan procedure, whereas 5 of the 8 with grade 2 or greater muscle extension died shortly thereafter (P = .001).
Immunohistochemical study
NOS immunostaining
In the control group eNOS reactivity was low in the pulmonary arteries (score, 0.88 ± 0.32; Figure 3, A) and mainly observed in endothelial cells of the proximal and distal muscular pulmonary arteries and capillaries. Endothelial NOS was also detected in the bronchiolar epithelium to a lesser extent. No difference was noted between the proximal and distal pulmonary arteries regarding the staining intensity (Figure 4).
|
|
In contrast, group 2 patients exhibited a strong eNOS immunoreactivity in the pulmonary vascular endothelium of their proximal and distal intrapulmonary arteries (score, 1.86 ± 0.88; P < .01 vs group 1; Figure 3
, C).
There was a good correlation between the histomorphometric and immunohistochemical results, except for patients 8 and 9 (r = 0.76, P = .001; Figure 5).
|
|
In group 1 ET-1 expression remained low (score, 0.9 ± 0.3) and comparable with that of the control subjects (0.7 ± 0.2), whereas group 2 patients exhibited a more intense ET-1 immunoreactivity (score, 1.3 ± 0.3) than the control subjects (P < .01). The difference between immunoreactivity observed in the proximal pulmonary arteries of groups 1 and 2 was not significant (Figure 6
).
| Discussion |
|---|
|
|
|---|
We postulated that endothelial dysfunction might be at least partly responsible for this situation.
To find out whether markers of such dysfunction could be evidenced in patients with a failed procedure, we retrospectively evaluated the pulmonary vascular structure and the expression of endothelial vasoactive factors in lung biopsy specimens obtained during surgical intervention from patients undergoing the Fontan procedure. For this purpose, we used both histomorphometric criteria and immunohistochemical markers of eNOS and ET-1 expression on endothelium.
We could not find any differences between group 1 and 2 patients that were predictive of these histologic and immunohistochemical changes. Indeed, saturation, degree of pulmonary protection, surgical technique, aortic crossclamping time, and postoperative management were comparable in both groups. The only difference between groups is age. However, we would expect the opposite because the younger age of group 2 is usually recommended to avoid alteration of pulmonary vascular resistance or ventricular failure.
Our results showed abnormal muscle extension into the distal pulmonary arteries of the majority of patients in whom surgical intervention failed. Indeed, although group 1 patients exhibited normal distal pulmonary artery muscularity in all but one patient, 7 of the 9 patients in group 2 had muscle extension in the distal pulmonary arteries of grade 2 or greater. It should be underlined that most of these samples would have been considered as normal by using standard pathologic criteria because the changes in the muscularity of the distal pulmonary arteries were minor. However, these arteries contribute greatly to pulmonary vascular resistance and to failure of the Fontan procedure because of an impaired vascular reactivity after a stimulus such as cardiopulmonary bypass.
We also postulated that expression of endothelial vasoactive factors might be altered in patients in whom the procedure failed, as observed in patients with pulmonary hypertension.
11,12 Immunoreactivity was indeed weak for both eNOS and ET-1 in group 1 patients and similar to that of the control group. By contrast, eNOS was intensely expressed in the vascular endothelium of group 2. Endothelial NOS expression was comparable all along the arterial axis. It was significantly stronger in group 2 patients than in group 1 patients and control subjects. It should be underlined that this criterion might appear as more sensitive than histomorphometry. Indeed, patients 9 and 12 had normal distal wall thickness but increased eNOS reactivity, and their operations failed. Patient 8 had thick-walled distal pulmonary arteries with only a slight increase in NOS expression. This patient had an overall good outcome, despite a pleural effusion for 12 days.
Altogether, all 9 patients whose Fontan procedures failed exhibited a marked expression of NOS and ET-1 compared with that seen in the control subjects, despite a low pulmonary pressure.
Overexpression of endothelial factors in patients with failure of the procedure might indicate an endothelial dysfunction. Increased shear stress caused by abnormal pulmonary blood flow, and polycythemia might cause endothelial dysfunction with overstimulation of the nitric oxide pathway to maintain low pulmonary pressure. Endothelial NOS is indeed upregulated in shunt-induced pulmonary hypertension in lambs, in rats exposed to hypoxia, and in polycythemic rats.
17-20 By contrast, in adult patients with pulmonary hypertension, eNOS expression is reduced.
11,12 The mechanism underlying pulmonary hypertension might be involved in the differences between endothelial factor synthesis because eNOS is upregulated in shunt-induced pulmonary hypertension, whereas it is reduced in ductus arteriosus ligation.
17,21 However, 4 patients with successful operations had increased pulmonary blood flow without the eNOS overexpression observed in all patients in whom surgical intervention failed. Therefore, increased pulmonary blood flow does not necessarily impair endothelial functions. Unlike adult patients with primary pulmonary hypertension, the eNOS is upregulated in our patients with failed Fontan procedures. This could be due to an attempt to improve the pulmonary vascular resistance and facilitate the Fontan circulation. Indeed, adult patients with primary pulmonary hypertension could have an incapacity to produce eNOS, which is not the case in our population. Whether this upregulation of eNOS is to balance the endothelin production or the lack of other vasodilative substances remains to be elucidated.
Of interest is the fact that histomorphometric and immunohistochemical data were correlated (P = .001). The former data appear to have a good predictive value, but the latter might be more sensitive. Bearing in mind that immunohistochemistry only allows for a semiquantitative assessment of protein expression, we are currently investigating the possibility of more accurate procedures, Western blotting, and enzyme-linked immunosorbent assay to quantify eNOS activity and ET-1 on frozen tissues.
The results of this study warrant further investigation of these markers by a prospective study of patients considered good candidates for the Fontan procedure. Our results might support the idea that this procedure should be performed in 2 steps, with a lung biopsy performed during the first step (ie, the partial cavopulmonary connection). This sample would undergo histomorphometric studies, immunohistochemical studies, and quantification of eNOS and ET-1, and the decision concerning whether to complete the procedure would be based on the absence of endothelial dysfunction.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Cai, Z. Su, Z. Shi, Y. Zhou, Z. Xu, Z. Xu, and Y. Yang Nitric Oxide and Milrinone: Combined Effect on Pulmonary Circulation After Fontan-Type Procedure: A Prospective, Randomized Study Ann. Thorac. Surg., September 1, 2008; 86(3): 882 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nemoto, E. Umehara, T. Ikeda, T. Itonaga, and M. Komeda Oral Sildenafil Ameliorates Impaired Pulmonary Circulation Early After Bidirectional Cavopulmonary Shunt Ann. Thorac. Surg., May 1, 2007; 83(5): e11 - e13. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |